Longaandoening airways obstruction
Conditions
Interventions
At each planned and unplanned visit to the general practice the treatment step
will be adjusted with support of an ICT-based asthma monitoring system
supervised by a central coordinating specialist
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria (all of the following criteria) - age 18-50 yr - doctors diagnosis of asthma - patients who need inhaled corticosteroids as controller medication (step 2-4 GINA guidelines) - inhaled corticosteroids >= 3 months in the previous year - written informed consent - no exacerbation of asthma within 1 month before entry
Exclusion criteria
Exclusion criteria: - daily or alternate day oral corticosteroid therapy within 1 month before entering the study - inability to understand written or oral Dutch instructions - active diseases likely to interfere with the purpose of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end-point is the evaluation of the cost-effectiveness of treatment strategies by incremental net-benefit analysis. Net health benefit addresses cost-effectiveness ratios by assuming values for the willingness-to-pay per unit of effectiveness. Sensitivity analyses will be performed on the perspective (societal versus health care) and the applied utility measure (Dutch EQ5D, SF6D, e-TTO, VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary end-points include asthma related quality of life (AQLQ), the number of limited activity days and patient preferences. | — |
Countries
Netherlands
Outcome results
None listed